Casey G - Search Results

1

Deciphering the genetic architecture of low-penetrance susceptibility to colorectal cancer.

Whiffin N, Dobbins SE, Hosking FJ, Palles C, Tenesa A, Wang Y, Farrington SM, Jones AM, Broderick P, Campbell H, Newcomb PA, Casey G, Conti DV, Schumacher F, Gallinger S, Lindor NM, Hopper J, Jenkins M, Dunlop MG, Tomlinson IP, Houlston RS. Whiffin N, et al. Among authors: casey g. Hum Mol Genet. 2013 Dec 15;22(24):5075-82. doi: 10.1093/hmg/ddt357. Epub 2013 Jul 30. Hum Mol Genet. 2013. PMID: 23904454 Free PMC article.

2

Prostate cancer aggressiveness locus on chromosome 7q32-q33 identified by linkage and allelic imbalance studies.

Neville PJ, Conti DV, Paris PL, Levin H, Catalona WJ, Suarez BK, Witte JS, Casey G. Neville PJ, et al. Among authors: casey g. Neoplasia. 2002 Sep-Oct;4(5):424-31. doi: 10.1038/sj.neo.7900254. Neoplasia. 2002. PMID: 12192601 Free PMC article.

3

Prostate cancer aggressiveness locus on chromosome segment 19q12-q13.1 identified by linkage and allelic imbalance studies.

Neville PJ, Conti DV, Krumroy LM, Catalona WJ, Suarez BK, Witte JS, Casey G. Neville PJ, et al. Among authors: casey g. Genes Chromosomes Cancer. 2003 Apr;36(4):332-9. doi: 10.1002/gcc.10165. Genes Chromosomes Cancer. 2003. PMID: 12619157

4

CYP3A4 and CYP3A5 genotypes, haplotypes, and risk of prostate cancer.

Plummer SJ, Conti DV, Paris PL, Curran AP, Casey G, Witte JS. Plummer SJ, et al. Among authors: casey g. Cancer Epidemiol Biomarkers Prev. 2003 Sep;12(9):928-32. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 14504207

5

Comprehensive evaluation of the association between prostate cancer and genotypes/haplotypes in CYP17A1, CYP3A4, and SRD5A2.

Loukola A, Chadha M, Penn SG, Rank D, Conti DV, Thompson D, Cicek M, Love B, Bivolarevic V, Yang Q, Jiang Y, Hanzel DK, Dains K, Paris PL, Casey G, Witte JS. Loukola A, et al. Among authors: casey g. Eur J Hum Genet. 2004 Apr;12(4):321-32. doi: 10.1038/sj.ejhg.5201101. Eur J Hum Genet. 2004. PMID: 14560315

6

DNA repair gene XRCC1 and XPD polymorphisms and risk of prostate cancer.

Rybicki BA, Conti DV, Moreira A, Cicek M, Casey G, Witte JS. Rybicki BA, et al. Among authors: casey g. Cancer Epidemiol Biomarkers Prev. 2004 Jan;13(1):23-9. doi: 10.1158/1055-9965.epi-03-0053. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 14744728

7

Association of prostate cancer risk and aggressiveness to androgen pathway genes: SRD5A2, CYP17, and the AR.

Cicek MS, Conti DV, Curran A, Neville PJ, Paris PL, Casey G, Witte JS. Cicek MS, et al. Among authors: casey g. Prostate. 2004 Apr 1;59(1):69-76. doi: 10.1002/pros.10358. Prostate. 2004. PMID: 14991867

8

Relationship between methylenetetrahydrofolate reductase C677T and A1298C genotypes and haplotypes and prostate cancer risk and aggressiveness.

Cicek MS, Nock NL, Li L, Conti DV, Casey G, Witte JS. Cicek MS, et al. Among authors: casey g. Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1331-6. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15298954

9

Podocalyxin variants and risk of prostate cancer and tumor aggressiveness.

Casey G, Neville PJ, Liu X, Plummer SJ, Cicek MS, Krumroy LM, Curran AP, McGreevy MR, Catalona WJ, Klein EA, Witte JS. Casey G, et al. Hum Mol Genet. 2006 Mar 1;15(5):735-41. doi: 10.1093/hmg/ddi487. Epub 2006 Jan 24. Hum Mol Genet. 2006. PMID: 16434482

10

Toll-like receptor 4 genetic variation and advanced prostate cancer risk.

Cheng I, Plummer SJ, Casey G, Witte JS. Cheng I, et al. Among authors: casey g. Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):352-5. doi: 10.1158/1055-9965.EPI-06-0429. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17301271

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

688 results

Search Page